Vizient, Fresenius Kabi to supply 6 critical care drugs

Vizient signed an agreement Nov. 21 with German drugmaker Fresenius Kabi to supply six critical care drugs through its Novaplus pharmacy program. 

Advertisement

The six drugs include propofol, an anesthesia drug manufactured by Fresenius Kabi that is sold as Diprivan. The other drugs are protamine, phenylephrine, oxytocin, thiamine and magnesium sulfate. 

The drugs are the first critical care drugs added to Novaplus, a program intended to offset drug shortages by better anticipating demand. 

Read the full news release here

More articles on pharmacy:
AHA, CVS Health backed secretive anti-pharma group
EpiPen, Humira among drugs Warren wants to regulate
31 drugmakers at high risk for bankruptcy in 2020

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.